Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism

Clinica Chimica Acta

Volumn 372, Issue 1-2, 2006, Pages 33-42

  Speeckaert, Marijn ^a   Huang, Guangming ^a   Delanghe, Joris R ^a   Taes, Youri E C ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Actin scavenger system; Gc globulin; Polymorphism; Vitamin D binding protein

Indexed keywords

AFAMIN; ALBUMIN; ALBUMINOID; ALPHA ALBUMIN; ALPHA FETOPROTEIN; F ACTIN; G ACTIN; MACROPHAGE ACTIVATING FACTOR; PROTEIN; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; AMINO ACID SEQUENCE; ANALYTIC METHOD; ANTHROPOLOGY; AUTOIMMUNITY; BONE METABOLISM; CHEMOTAXIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; FATTY ACID TRANSPORT; GENE CLUSTER; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INFLAMMATION; INJURY; LIVER DISEASE; LIVER FAILURE; LUNG DISEASE; MULTIPLE SCLEROSIS; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN METABOLISM; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN VARIANT; REVIEW; RHEUMATIC FEVER; SARCOIDOSIS; SEQUENCE HOMOLOGY;

DISEASE; HUMANS; POLYMORPHISM, GENETIC; VITAMIN D-BINDING PROTEIN;

EID: 33747854680     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.03.011     Document Type: Review

References (106)

1. Cooke N.E., and David E.V. Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J Clin Invest 76 (1985) 2420-2424
2. Kawakami M., Blum C.B., Ramakrishnan R., Dell R.B., and Goodman D.S. Turnover of the plasma binding protein for vitamin D and its metabolites in normal human subjects. J Clin Endocrinol Metab 53 (1981) 1110-1116
3. Braun A., Kofler A., Morawietz S., and Cleve H. Sequence and organization of the human vitamin D-binding protein gene. Biochim Biophys Acta 1216 (1993) 385-394
4. Cooke N.E., McLeod J.F., Wang X.K., and Ray K. Vitamin D binding protein: genomic structure, functional domains, and mRNA expression in tissues. J Steroid Biochem Mol Biol 40 (1991) 787-793
5. White P., and Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 11 (2000) 320-327
6. Bouillon R., Van Assche F.A., Van Baelen H., Heyns W., and De Moor P. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest 67 (1981) 589-596
7. Aarskog D., Aksnes L., Markestad T., and Rodland O. Effect of estrogen on vitamin D metabolism in tall girls. J Clin Endocrinol Metab 57 (1983) 1155-1158
8. Dick I.M., Prince R.L., Kelly J.J., and Ho K.K. Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administration. Clin Endocrinol (Oxf) 43 (1995) 219-224
9. Cooke N.E., and Haddad J.G. Vitamin D binding protein (Gc-Globulin). Endocr Rev 10 (1989) 294-307
10. Haddad J.G., Fraser D.R., and Lawson D.E. Vitamin D plasma binding protein. Turnover and fate in the rabbit. J Clin Invest 67 (1981) 1550-1560
11. Ray K., Wang X.K., Zhao M., and Cooke N.E. The rat vitamin D binding protein (Gc-globulin) gene. Structural analysis, functional and evolutionary correlations. J Biol Chem 266 (1991) 6221-6229
12. Cooke N.E. Rat vitamin D binding protein. Determination of the full-length primary structure from cloned cDNA. J Biol Chem 261 (1986) 3441-3450
13. Song Y.H., Naumova A.K., Liebhaber S.A., and Cooke N.E. Physical and meiotic mapping of the region of human chromosome 4q11-q13 encompassing the vitamin D binding protein DBP/Gc-globulin and albumin multigene cluster. Genome Res 9 (1999) 581-587
14. Hay A.W., and Watson G. The plasma transport proteins of 25-hydroxycholecalciferol in fish, amphibians, reptiles and birds. Comp Biochem Physiol B 53 (1976) 167-172
15. Haefliger D.N., Moskaitis J.F., Schoenberg D.R., and Wahli W. Amphibian albumins as members of the albumin, alpha-fetoprotein, vitamin D-binding protein multigene family. J Mol Evol 29 (1989) 344-354
16. Constans J., Gouaillard C., Bouissou C., and Dugoujon J.M. Polymorphism of the vitamin D binding protein (DBP) among primates: an evolutionary analysis. Am J Phys Anthropol 74 (1987) 365-377
17. Cleve H., and Constans J. The mutants of the vitamin D-binding protein: more than 120 variants of the Gc/DBP system. Vox Sang 54 (1988) 215-225
18. Arnaud J., and Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet 92 (1993) 183-188
19. Braun A., Bichlmaier R., and Cleve H. Molecular analysis of the gene for the human vitamin D-binding protein (group-specific component): allelic differences of the common genetic Gc types. Hum Genet 89 (1992) 401-406
20. Viau M., Constans J., Debray H., and Montreuil J. Isolation and characterization of the O-glycan chain of the human vitamin D-binding protein. Biochem Biophys Res Commun 117 (1983) 324-331
21. Haughton M.A., and Mason R.S. Immunonephelometric assay of vitamin D-binding protein. Clin Chem 38 (1992) 1796-1801
22. Imawari M., and Goodman D.S. Immunological and immunoassay studies of the binding protein for vitamin D and its metabolites in human serum. J Clin Invest 59 (1977) 432-442
23. Jorgensen C.S., Christiansen M., Norgaard-Pedersen B., et al. Gc globulin (vitamin D-binding protein) levels: an inhibition ELISA assay for determination of the total concentration of the Gc globulin in plasma and serum. Scand J Clin Invest 64 (2004) 157-166
24. Kamboh M.I., and Ferrell R.E. Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations. Hum Genet 72 (1986) 281-293
25. Daiger S.P., Schanfield M.S., and Cavalli-Sforza L.L. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci U S A 72 (1975) 2076-2080
26. Safadi F.F., Thornton P., Magiera H., et al. Osteopathy and resistance to vitamin D toxicity in mice null for the vitamin D binding protein. J Clin Invest 103 (1999) 239-251
27. Mendel C.M. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 10 (1989) 232-274
28. Ekins R. Measurement of free hormones in blood. Endocr Rev 11 (1990) 5-46
29. Bikle D.D., and Gee E. Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology 124 (1989) 649-654
30. Nykjaer A., Dragun D., Walther D., et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96 (1999) 507-515
31. van Hoof H.J., de Sevaux R.G., Van Baelen H., et al. Relationship between free and total 1,25-dihydroxyvitamin D in conditions of modified binding. Eur J Endocrinol 144 (2001) 391-396
32. Lauridsen A.L., Vestergaard P., Hermann A.P., et al. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 77 (2005) 15-22
33. Lauridsen A.L., Vestergaard P., and Nexo E. Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem 47 (2001) 753-756
34. Rejnmark L., Lauridsen A.L., Vestergaard P., Heickendorff L., Andreasen F., and Mosekilde L. Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolism. Eur J Endocrinol 146 (2002) 635-642
35. Bouillon R., Baelen H., and Moor P. Comparative study of the affinity of the serum vitamin D-binding protein. J Steroid Biochem 13 (1980) 1029-1034
36. Boutin B., Galbraith R.M., and Arnaud P. Comparative affinity of the major genetic variants of human group-specific component (vitamin D-binding protein) for 25-(OH) vitamin D. J Steroid Biochem 32 (1989) 59-63
37. Bouillon R., van Baelen H., and de Moor P. The measurement of the vitamin D-binding protein in human serum. J Clin Endocrinol Metab 45 (1977) 225-231
38. Van Baelen H., Bouillon R., and De Moor P. Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem 255 (1980) 2270-2272
39. Lee W.M., and Galbraith R.M. The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326 (1992) 1335-1341
40. Mc Leod J.F., Kowalski M.A., and Haddad Jr. J.G. Interactions among serum vitamin D binding protein, monomeric actin, profilin, and profilactin. J Biol Chem 264 (1989) 1260-1267
41. Harper K.D., McLeod J.F., Kowalski M.A., and Haddad J.G. Vitamin D binding protein sequesters monomeric actin in the circulation of the rat. J Clin Invest 79 (1987) 1365-1370
42. Haddad J.G., Hu Y.Z., Kowalski M.A., et al. Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (Gc-globulin). Biochemistry 31 (1992) 7174-7181
43. Sanger J.M., Dabiri G., Mittal B., Kowalski M.A., Haddad J.G., and Sanger J.W. Disruption of microfilament organization in living nonmuscle cells by microinjection of plasma vitamin D-binding protein or DNase I. Proc Natl Acad Sci U S A 87 (1990) 5474-5478
44. Dahl B., Schiodt F.V., Ott P., et al. Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit Care Med 31 (2003) 152-156
45. Ena J.M., Esteban C., Perez M.D., Uriel J., and Calvo M. Fatty acids bound to vitamin D-binding protein (DBP) from human and bovine sera. Biochem Int 19 (1989) 1-7
46. Williams M.H., Van Alstyne E.L., and Galbraith R.M. Evidence of a novel association of unsaturated fatty acids with Gc (vitamin D-binding protein). Biochem Biophys Res Commun 153 (1988) 1019-1024
47. Bouillon R., Xiang D.Z., Covents R., and Van Baelen H. Polyunsaturated fatty acids decrease the apparent affinity of vitamin D metabolites for human vitamin D-binding protein. J Steroid Biochem Mol Biol 42 (1992) 855-861
48. Calvo M., and Ena J.M. Relations between vitamin D and fatty acid binding properties of vitamin D-binding protein. Biochem Biophys Res Commun 163 (1989) 14-17
49. Yamamoto N., and Naraparaju V.R. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats. Cell Immunol 170 (1996) 161-167
50. Yamamoto N., and Kumashiro R. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells. J Immunol 151 (1993) 2794-2802
51. Schneider G.B., Benis K.A., Flay N.W., Ireland R.A., and Popoff S.N. Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone 16 (1995) 657-662
52. Yamamoto N., Lindsay D.D., Naraparaju V.R., Ireland R.A., and Popoff S.N. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats. J Immunol 152 (1994) 5100-5107
53. Schneider G.B., Grecco K.J., Safadi F.F., and Popoff S.N. The anabolic effects of vitamin D-binding protein-macrophage activating factor (DBP-MAF) and a novel small peptide on bone. Crit Rev Eukaryot Gene Expr 13 (2003) 277-284
54. Yamamoto N., Naraparaju V.R., and Orchard P.J. Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis. Blood 88 (1996) 1473-1478
55. Gumireddy K., Reddy C.D., and Swamy N. Mitogen-activated protein kinase pathway mediates DBP-MAF-induced apoptosis in RAW 264.7 macrophages. J Cell Biochem 90 (2003) 87-96
56. Kanda S., Mochizuki Y., Miyata Y., Kanetake H., and Yamamoto N. Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis. J Natl Cancer Inst 94 (2002) 1311-1319
57. Kisker O., Onizuka S., Becker C.M., et al. Vitamin D binding protein-macrophage activating factor (DBP-MAF) inhibits angiogenesis and tumor growth in mice. Neoplasia 5 (2003) 32-40
58. Kalkunte S., Brard L., Granai C.O., and Swamy N. Inhibition of angiogenesis by vitamin D-binding protein: characterization of anti-endothelial activity of DBP-MAF. Angiogenesis 7 (2006) 1-12
59. Perez H.D., Kelly E., Chenoweth D., and Elfman F. Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin). J Clin Invest 82 (1988) 360-363
60. Kew R.R., and Webster R.O. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. J Clin Invest 82 (1988) 364-369
61. McVoy L.A., and Kew R.R. CD44 and annexin A2 mediate the C5a chemotactic cofactor function of the vitamin D binding protein. J Immunol 175 (2005) 4754-4760
62. Binder R., Kress A., Kan G., Herrmann K., and Kirschfink M. Neutrophil priming by cytokines and vitamin D binding protein (Gc-globulin): impact on C5a-mediated chemotaxis, degranulation and respiratory burst. Mol Immunol 36 (1999) 885-892
63. Raymond M.A., Desormeaux A., Labelle A., et al. Endothelial stress induces the release of vitamin D-binding protein, a novel growth factor. Biochem Biophys Res Commun 338 (2005) 1374-1382
64. Eichner J.E., Cauley J.A., Ferrell R.E., Cummings S.R., and Kuller L.H. Genetic variation in two bone-related proteins: is there an association with bone mineral density or skeletal size in postmenopausal women?. Genet Epidemiol 9 (1992) 177-184
65. Lauridsen A.L., Vestergaard P., Hermann A.P., Moller H.J., Mosekilde L., and Nexo E. Female premenopausal fracture risk is associated with gc phenotype. J Bone Miner Res 19 (2004) 875-881
66. Rapado A., Hawkins F., Sobrinho L., et al. Bone mineral density and androgen levels in elderly males. Calcif Tissue Int 65 (1999) 417-421
67. Papiha S.S., Allcroft L.C., Kanan R.M., Francis R.M., and Datta H.K. Vitamin D binding protein gene in male osteoporosis: association of plasma DBP and bone mineral density with (TAAA)n-Alu polymorphism in DBP. Calcif Tissue Int 65 (1999) 262-266
68. Ezura Y., Nakajima T., Kajita M., et al. Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density. J Bone Miner Res 18 (2003) 1642-1649
69. Laing C.J., and Fraser D.R. Changes with malnutrition in the concentration of plasma vitamin D binding protein in growing rats. Br J Nutr 88 (2002) 133-139
70. Pani M.A., Regulla K., Segni M., et al. A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J Clin Endocrinol Metab 87 (2002) 2564-2567
71. Hirai M., Suzuki S., Hinokio Y., et al. Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance. J Clin Endocrinol Metab 85 (2000) 1951-1953
72. Szathmary E.J. The effect of Gc genotype on fasting insulin level in Dogrib Indians. Hum Genet 75 (1987) 368-372
73. Hirai M., Suzuki S., Hinokio Y., et al. Group specific component protein genotype is associated with NIDDM in Japan. Diabetologia 41 (1998) 742-743
74. Ye W.Z., Dubois-Laforgue D., Bellane-Chantellot C., Timsit J., and Velho G. Variations in the vitamin D-binding protein (Gc locus) and risk of type 2 diabetes mellitus in French Caucasians. Metabolism 50 (2001) 366-369
75. Klupa T., Malecki M., Hanna L., et al. Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin. Eur J Endocrinol 141 (1999) 490-493
76. Malecki M.T., Klupa T., Wanic K., Cyganek K., Frey J., and Sieradzki J. Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population. Diabetes Res Clin Pract 57 (2002) 99-104
77. Pani M.A., Donner H., Herwig J., Usadel K.H., and Badenhoop K. Vitamin D binding protein alleles and susceptibility for type 1 diabetes in Germans. Autoimmunity 31 (1999) 67-72
78. Snijder M.B., van Dam R.L., Visser M., et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 90 (2005) 4119-4123
79. Parikh S.J., Edelman M., Uwaifo G.I., et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89 (2004) 1196-1199
80. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., and Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72 (2000) 690-693
81. Taes YE, Goemaere S, Huang G, Van Pottelbergh I, De Bacquer D, Verhasselt B, et al. Vitamin D binding protein, bone status and body composition in community-dwelling elderly men. Bone 38 in press.
82. Sandford A.J., Weir T.D., and Pare P.D. Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J 10 (1997) 1380-1391
83. Kueppers F., Miller R.D., Gordon H., Hepper N.G., and Offord K. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 63 (1977) 336-342
84. Schellenberg D., Pare P.D., Weir T.D., Spinelli J.J., Walker B.A., and Sandford A.J. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med 157 (1998) 957-961
85. Kauffmann F., Kleisbauer J.P., Cambon-De-Mouzon A., et al. Genetic markers in chronic air-flow limitation. A genetic epidemiologic study. Am Rev Respir Dis 127 (1983) 263-269
86. Horne S.L., Cockcroft D.W., and Dosman J.A. Possible protective effect against chronic obstructive airways disease by the GC2 allele. Hum Hered 40 (1990) 173-176
87. Ito I., Nagai S., Hoshino Y., et al. Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. Chest 125 (2004) 63-70
88. Ishii T., Keicho N., Teramoto S., et al. Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur Respir J 18 (2001) 753-757
89. Black P.N., and Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey. Chest 128 (2005) 3792-3798
90. Lee W.M., Galbraith R.M., Watt G.H., et al. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology 21 (1995) 101-105
91. Constans J., Arlet P., Viau M., and Bouissou C. Unusual sialilation of the serum DBP associated with the Gc 1 allele in alcoholic cirrhosis of the liver. Clin Chim Acta 130 (1983) 219-230
92. Eales L.J., Nye K.E., Parkin J.M., et al. Association of different allelic forms of group specific component with susceptibility to and clinical manifestation of human immunodeficiency virus infection. Lancet 1 (1987) 999-1002
93. Alonso A., Montesino M., Inturralde M.J., et al. GC subtyping and HIV infection in a Spanish population: no evidence of an association between GC subtypes and AIDS. Hum Hered 40 (1990) 34-37
94. Cleve H., Weidinger S., Gurtler L.G., and Deinhardt F. AIDS: no association with the genetic systems GC (D-binding protein), ORM (orosomucoid = alpha-1-acid glycoprotein), and A2HS (alpha-2-HS-glycoprotein). Infection 16 (1988) 31-35
95. Pronk J.C., Frants R.R., Crusius B., et al. No predictive value of GC phenotypes for HIV infection and progression to AIDS. Hum Genet 80 (1988) 181-182
96. Niino M., Kikuchi S., Fukazawa T., Yabe I., and Tashiro K. No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS. J Neuroimmunol 127 (2002) 177-179
97. Milman N., Thymann M., Graudal N., and Morling N. Plasma vitamin D-binding protein (GC) factors, immunoglobulin G heavy chain (GM) allotypes and immunoglobulin kappa light chain (KM1) allotype in patients with sarcoidosis and in healthy control subjects. Sarcoidosis Vasc Diffuse Lung Dis 19 (2002) 97-100
98. Bahr G.M., Eales L.J., Nye K.E., et al. An association between Gc (vitamin D-binding protein) alleles and susceptibility to rheumatic fever. Immunology 67 (1989) 126-128
99. Dahl B., Schiodt F.V., Kiaer T., Ott P., Bondesen S., and Tygstrup N. Serum Gc-globulin in the early course of multiple trauma. Crit Care Med 26 (1998) 285-289
100. Dahl B., Schiodt F.V., Rudolph S., Ott P., Kiaer T., and Heslet L. Trauma stimulates the synthesis of Gc-globulin. Intensive Care Med 27 (2001) 394-399
101. Dahl B., Schiodt F.V., Nielsen M., Kiaer T., Williams J.G., and Ott P. Admission level of Gc-globulin predicts outcome after multiple trauma. Injury 30 (1999) 275-281
102. Dahl B., Schiodt F.V., Gehrchen P.M., Ramlau J., Kiaer T., and Ott P. Gc-globulin is an acute phase reactant and an indicator of muscle injury after spinal surgery. Inflamm Res 50 (2001) 39-43
103. Walsh P.G., and Haddad J.G. "Rocket" immunoelectrophoresis assay of vitamin D-binding protein (Gc globulin) in human serum. Clin Chem 28 (1982) 1781-1783
104. Raouf A.A., Geisow M.J., O'Gorman P., Marsden P., and Howorth P.J. A method for the preparation of human thyroxine-binding globulin; its importance in the establishment of an accurate and specific radioimmunoassay. Clin Chim Acta 104 (1980) 25-41
105. Racadot A., Racadot-Leroy N., Le Gaillard F., and Dautrevaux M. Determination of serum transcortin levels by electroimmunodiffusion. Clin Chim Acta 66 (1976) 171-180
106. Cheng C.Y., Bardin C.W., Musto N.A., Gunsalus G.L., Cheng S.L., and Ganguly M. Radioimmunoassay of testosterone-estradiol-binding globulin in humans: a reassessment of normal values. J Clin Endocrinol Metab 56 (1983) 68-75